Image courtesy Fluidic Analytics
Fluidic Analytics Limited, a company founded by Professor Tuomas Knowles in the department, has raised £5.3 million in Series B financing.
The company is revolutionising the field of protein characterisation through its new technology that allows proteins to be characterised in a rapid, accurate and cost-effective manner.
The technology behind Fluidic Analytics’ innovative microfluidics platform is described in papers published in Analytical Chemistry, Nature Chemistry and ACS Nano.
Along with Professors Chris Dobson and Michele Vendruscolo, Professor Knowles is a director of the Centre for Misfolding Diseases, whose primary mission is to develop a fundamental understanding of the molecular origins of the variety of disorders associated with the misfolding and aggregation of proteins, which include Parkinson's disease, ALS and type II diabetes as well as Alzheimer's disease, and then to use such understanding for the rational design of novel therapeutic strategies.